Scout Investments, Inc. Halozyme Therapeutics, Inc. Transaction History

Scout Investments, Inc.

$3.4 Billion
Q3 2024

A detailed history of Scout Investments, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Scout Investments, Inc. holds 188,394 shares of HALO stock, worth $8.96 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

188,394

Previous 218,881 13.93%

Holding current value

$8.96 Million

Previous $11.5 Million 5.95%

% of portfolio

0.32%

Previous 0.33%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$51.3 - $64.42 $1.56 Million - $1.96 Million	-30,487 Reduced 13.93%	188,394 $10.8 Million
Q2 2024 Aug 12, 2024	SELL	$37.81 - $52.4 $1.02 Million - $1.41 Million	-26,980 Reduced 10.97%	218,881 $11.5 Million
Q1 2024 May 09, 2024	SELL	$33.68 - $41.95 $526,148 - $655,342	-15,622 Reduced 5.97%	245,861 $10 Million
Q4 2023 Feb 13, 2024	SELL	$33.32 - $42.1 $136,445 - $172,399	-4,095 Reduced 1.54%	261,483 $9.66 Million
Q3 2023 Nov 09, 2023	SELL	$36.46 - $44.03 $281,471 - $339,911	-7,720 Reduced 2.82%	265,578 $10.1 Million
Q2 2023 Aug 14, 2023	SELL	$30.28 - $38.74 $246,751 - $315,692	-8,149 Reduced 2.9%	273,298 $9.86 Million
Q1 2023 May 11, 2023	SELL	$32.86 - $55.7 $108,339 - $183,642	-3,297 Reduced 1.16%	281,447 $10.7 Million
Q4 2022 Jan 23, 2023	SELL	$40.06 - $59.44 $592,247 - $878,760	-14,784 Reduced 4.94%	284,744 $0
Q3 2022 Oct 18, 2022	BUY	$38.53 - $51.78 $3,621 - $4,867	94 Added 0.03%	299,528 $11.8 Million
Q2 2022 Jul 15, 2022	BUY	$37.35 - $48.3 $295,587 - $382,246	7,914 Added 2.71%	299,434 $13.2 Million
Q1 2022 Apr 14, 2022	SELL	$31.97 - $41.06 $12,116 - $15,561	-379 Reduced 0.13%	291,520 $11.6 Million
Q4 2021 Jan 14, 2022	SELL	$31.82 - $40.75 $208,580 - $267,116	-6,555 Reduced 2.2%	291,899 $11.7 Million
Q3 2021 Oct 13, 2021	SELL	$38.47 - $46.42 $470,795 - $568,087	-12,238 Reduced 3.94%	298,454 $12.1 Million
Q2 2021 Jul 23, 2021	SELL	$38.84 - $51.31 $1.01 Million - $1.34 Million	-26,062 Reduced 7.74%	310,692 $14.1 Million
Q1 2021 Apr 09, 2021	BUY	$39.51 - $51.45 $1.35 Million - $1.76 Million	34,251 Added 11.32%	336,754 $14 Million
Q4 2020 Jan 12, 2021	BUY	$25.81 - $43.62 $221,966 - $375,132	8,600 Added 2.93%	302,503 $12.9 Million
Q3 2020 Oct 13, 2020	BUY	$25.74 - $29.63 $1.41 Million - $1.62 Million	54,709 Added 22.87%	293,903 $7.72 Million
Q2 2020 Jul 14, 2020	BUY	$16.25 - $26.81 $3.89 Million - $6.41 Million	239,194 New	239,194 $6.41 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scout Investments, Inc. with notifications on news.

Account

Scout Investments, Inc. Halozyme Therapeutics, Inc. Transaction History